40 participants
Trial to Evaluate Efficacy and Safety of Subcutaneous Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma .
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-11
- Start Date:
- 2026-01-05
- Completion:
- 2028-04-01
Conditions
- Follicular Lymphoma
Interventions
- DRUG
No Results Yet